Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients

Osnabrugge, Ruben L J; Head, Stuart J; Genders, Tessa S S; Van Mieghem, Nicolas M; De Jaegere, Peter P T; van der Boon, Robert M A; Kerkvliet, J Marco; Kalesan, Bindu; Bogers, Ad J J C; Kappetein, A Pieter; Hunink, M G Myriam (2012). Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Annals of thoracic surgery, 94(6), pp. 1954-60. New York, N.Y.: Elsevier 10.1016/j.athoracsur.2012.07.002

Text Osnabrugge AnnThoracSurg 2012.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (196kB)

Transcatheter aortic valve replacement (TAVR) offers a new treatment option for patients with aortic stenosis, but costs may play a decisive role in decision making. Current studies are evaluating TAVR in an intermediate-risk population. We assessed the in-hospital and 1-year follow-up costs of patients undergoing TAVR and surgical aortic valve replacement (SAVR) at intermediate operative risk and identified important cost components.

Interest & Impact

Downloads

1 since deposited on 04 Oct 2013
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item